Submit Manuscript

International Journal of Cancer Research

Year: 2016 | Volume: 12 | Issue: 3-4 | Page No.: 128-139
Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail

Article Trend

Total views 544

Search

Authors

HebatAllah Mohamed Shaaban

Nesreen Hassan Hafez

Halla Mohamed Ragab

Areeg Ibrahim El Abadi

Keywords

Background: Survivin, a member of the inhibitor of apoptotic protein family is involved in cell proliferation and apoptotic suppression. Survivin is highly expressed in many cancers and correlated with more aggressive disease. Objective: Assessment of survivin expression in breast carcinoma and its association with clinicopathological factors. Materials and Methods: One hundred and eight breast carcinoma and 22 control benign specimens were used for survivin immunohistochemical assessment. Survivin expression was evaluated according to staining intensity and percentage of positive cells. A numerical score was calculated by multiplying them. Cases with scores of ≥1 were considered positive. Results: Survivin expression was obviously higher in malignant cases compared to the control cases (p<0.001). Among the clinicopathological parameters analyzed, significant correlations were established with the patient’s age (p<0.001), the size of the tumors (p = 0.005) and HER2 status (p = 0.05). Cytoplamic staining was detected in all positive cases, either alone (62.0%) or associated with nuclear staining (38.0%). Cytoplasmic staining only was significantly correlated with good prognostic parameters; small sized tumor, grade II, ER-positive and HER2-negative tumors (p<0.05). All triple negative cases (100%), 90% of luminal B and 72.2% of HER2 subtype showed survivin positivity, while only 48.7% of luminal A was positive. The association between survivin expression and molecular classification was insignificant (p = 0.069). Conclusion: Survivin has a potential role in diagnosis of malignancy. Survivin expression is associated with younger age, large tumor size, HER2-positive tumor and triple negative molecular subtype. Cytoplasmic staining was correlated with good prognostic parameters.
PDF Fulltext XML References Citation

How to cite this article

HebatAllah Mohamed Shaaban, Nesreen Hassan Hafez, Halla Mohamed Ragab and Areeg Ibrahim El Abadi, 2016. Nuclear and Cytoplasmic Expression of Survivin in Breast Carcinoma: Correlation with Clinicopathological Parameters. International Journal of Cancer Research, 12: 128-139.

DOI: 10.3923/ijcr.2016.128.139

URL: https://scialert.net/abstract/?doi=ijcr.2016.128.139

Leave a Comment

Your email address will not be published. Required fields are marked *